These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24048493)

  • 1. Effects of antihypertensive drugs on central blood pressure: new evidence, more challenges.
    Pucci G; Battista F; Schillaci G
    Hypertens Res; 2014 Jan; 37(1):10-2. PubMed ID: 24048493
    [No Abstract]   [Full Text] [Related]  

  • 2. Is validation of non-invasive hemodynamic measurement devices actually required?
    Salvi P
    Hypertens Res; 2014 Jan; 37(1):7-9. PubMed ID: 24048491
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study.
    Kim EJ; Song WH; Lee JU; Shin MS; Lee S; Kim BO; Hong KS; Han SW; Park CG; Seo HS
    Hypertens Res; 2014 Jan; 37(1):50-6. PubMed ID: 24026037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA; Savel'eva SA
    Kardiologiia; 2008; 48(4):18-24. PubMed ID: 18447835
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulse pressure and antihypertensive agents.
    Safar ME; O'Rourke MF
    Hypertension; 2005 Aug; 46(2):e6; author reply e6-7. PubMed ID: 16027242
    [No Abstract]   [Full Text] [Related]  

  • 6. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.
    Fleming T; Borer J; Armstrong PW; Pfeffer M;
    Circulation; 2003 Jan; 107(2):e9002-3. PubMed ID: 12538443
    [No Abstract]   [Full Text] [Related]  

  • 7. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension].
    Perocchio M; Gigli G; Barra M; Sacchetti R; Vallebona A; Rosolen GA; Orlandi S
    Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta blocker therapy for elderly hypertensive patients].
    MMW Fortschr Med; 2000 Feb; 142(7):54-5. PubMed ID: 10832341
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
    Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
    [No Abstract]   [Full Text] [Related]  

  • 13. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carvedilol].
    Antepohl W; Herzig S; Böhm M
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol outclasses the other beta-blockers.
    Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
    [No Abstract]   [Full Text] [Related]  

  • 18. Carvedilol in hypertension.
    Raftery EB
    Cardiology; 1993; 82 Suppl 3():40-4. PubMed ID: 8106164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].
    Latfullin IA; Ishmurzin GP; Gaĭfullina RF; Akhmerova RI; Kim ZF; Podol'skaia AA
    Klin Med (Mosk); 2010; 88(2):68-71. PubMed ID: 21105477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.